At a House Subcommittee on Health hearing today, Congressman John Sarbanes (D-Md.) voiced support for medical cannabis research and highlighted the obstacles that current federal regulations pose to universities and research institutions hoping to study the health benefits of cannabis.
“I’ve heard from schools in my state, such as the University of Maryland Baltimore (UMB), that have communicated to me the difficulty in conducting research due to the current regulations and are nervous that any unintended violation of these strict and arduous restrictions could result in loss of their federal research grants,” said Congressman Sarbanes. “Despite these barriers, schools and researchers are eager to advance the understanding of this topic.”
Sarbanes continued: “A survey of health providers from 2015 concluded that the health providers themselves perceive a knowledge gap in areas relating to medical cannabis dosing, development of therapeutic treatment plans, differences between various cannabis products and other areas.”
Sarbanes concluded: “Incentivizing research on medical cannabis, for starters, would help address these knowledge gaps and support a more informed and robust provider workforce.”